Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Jupiter Neurosciences, Inc. (JUNS) had Consolidated Net Income/Loss of $-2.27M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.02M |
|
$-2.27M |
|
$0.00M |
|
$0.02M |
|
$2.77M |
|
$-2.74M |
|
$0.47M |
|
$-2.27M |
|
$-2.27M |
|
$-2.27M |
|
$-2.27M |
|
|
Consolidated Net Income/Loss |
$-2.27M |
$-2.27M |
|
$-2.74M |
|
$-2.74M |
|
0.56M |
|
0.56M |
|
$-4.08 |
|
$-4.08 |
|
| Balance Sheet Financials | |
$2.55M |
|
-- |
|
$1.17M |
|
$3.72M |
|
$3.88M |
|
-- |
|
$0.21M |
|
$4.08M |
|
$-0.37M |
|
$-0.37M |
|
$-0.37M |
|
0.67M |
|
| Cash Flow Statement Financials | |
$-3.73M |
|
-- |
|
$1.46M |
|
$3.79M |
|
$1.52M |
|
$-2.27M |
|
$0.99M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.66 |
|
-- |
|
-- |
|
-- |
|
-4.18 |
|
86.88% |
|
-11313.45% |
|
-11313.45% |
|
-- |
|
-9380.89% |
|
-9380.89% |
|
$-3.73M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.02 |
|
2.37 |
|
38.02 |
|
621.48% |
|
621.48% |
|
-61.16% |
|
621.48% |
|
$-0.55 |
|
$-6.68 |
|
$-6.68 |
|